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Abstract 
Antibiotics can be administered via various routes in pigs, which may influence antimicrobial resistance 
development. A total of 40 barrows and 40 gilts (Line 600 × 241; DNA, Columbus, NE; initially 207 ± 7.9 lb) 
were used in a 35-d trial to determine the effects of tylosin administration route on pig growth 
performance and development of antimicrobial resistance in fecal Enterococcus spp. isolates. Pens of 
pigs (1 pig/ pen, 20 pigs/treatment) were blocked by initial body weight (BW) and gender. Within blocks, 
pens were randomly allotted to 1 of 4 treatments. The antibiotic treatments followed US label directions 
and were: 1) no antibiotic (Control); 2) 110 mg tylosin per kg of feed for 21 d (Feed); 3) 8.82 mg tylosin per 
kg of BW through intramuscular injection twice daily for the first 3 d of each wk during the 3-wk treatment 
period (Injection); and 4) 66 mg of tylosin per liter of drinking water for the first 3 d of each wk during 
treatment period (Water). Treatments were offered during d 0 to 21, after which all pigs were fed a 
common diet with no antibiotic until d 35. Fecal samples were collected on d 0, 21, and 35. No evidence 
for route × gender interactions (P > 0.55) were observed for any growth responses. From d 0 to 21, control 
pigs and pigs fed medicated feed had greater (P < 0.05) average daily gain (ADG) than those that received 
injected tylosin, with the ADG of pigs receiving tylosin through the water intermediate. There was no 
evidence for different average daily feed intake (ADFI) among treatment groups. Pigs that received tylosin 
through injection or water had poorer (P < 0.05) feed efficiency (F/G) compared with control pigs, but 
there was no evidence for difference from pigs receiving tylosin through feed. Among the medicated pigs, 
total tylosin dose administered was the greatest through injection, second highest through feed, with the 
water medication route the lowest. No evidence for route × day interactions (P > 0.23) were observed for 
the development of bacterial resistance to any antibiotics. Enterococcal isolates collected from pigs 
receiving tylosin via feed or injection were more resistant (P < 0.05) to erythromycin and tylosin compared 
with control pigs and those that received tylosin through water. The estimated probability of antimicrobial 
resistance to these 2 antibiotics was greater on d 21 and 35 than d 0. In summary, tylosin injection 
resulted in poorer ADG and F/G of finishing pigs, likely due to stress associated with handling and 
injection. Tylosin administration through injection and feed resulted in greater probability of enterococcal 
resistance to erythromycin and tylosin compared with in-water treatment, which is likely a combined 
effect of administration route and dosage. 
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Effects of Tylosin Administration Routes 
on the Development of Antimicrobial 
Resistance in Fecal Enterococci of Finishing 
Swine1
F. Wu, M.D. Tokach, J.M. DeRouchey, S.S. Dritz,2 J.C. Woodworth, 
R.D. Goodband, K. Chitakasempornkul,3 N.M. Bello,3 K. Capps,2 
S. Remfry,4 R.G. Amachawadi,4 and T.G. Nagaraja2
Summary
Antibiotics can be administered via various routes in pigs, which may influence anti-
microbial resistance development. A total of 40 barrows and 40 gilts (Line 600 × 241; 
DNA, Columbus, NE; initially 207 ± 7.9 lb) were used in a 35-d trial to determine 
the effects of tylosin administration route on pig growth performance and develop-
ment of antimicrobial resistance in fecal Enterococcus spp. isolates. Pens of pigs (1 pig/
pen, 20 pigs/treatment) were blocked by initial body weight (BW) and gender. Within 
blocks, pens were randomly allotted to 1 of 4 treatments. The antibiotic treatments 
followed US label directions and were: 1) no antibiotic (Control); 2) 110 mg tylosin 
per kg of feed for 21 d (Feed); 3) 8.82 mg tylosin per kg of BW through intramuscular 
injection twice daily for the first 3 d of each wk during the 3-wk treatment period 
(Injection); and 4) 66 mg of tylosin per liter of drinking water for the first 3 d of each 
wk during treatment period (Water). Treatments were offered during d 0 to 21, after 
which all pigs were fed a common diet with no antibiotic until d 35. Fecal samples were 
collected on d 0, 21, and 35. No evidence for route × gender interactions (P > 0.55) 
were observed for any growth responses. From d 0 to 21, control pigs and pigs fed medi-
cated feed had greater (P < 0.05) average daily gain (ADG) than those that received 
injected tylosin, with the ADG of pigs receiving tylosin through the water intermediate. 
There was no evidence for different average daily feed intake (ADFI) among treatment 
groups. Pigs that received tylosin through injection or water had poorer (P < 0.05) feed 
efficiency (F/G) compared with control pigs, but there was no evidence for difference 
from pigs receiving tylosin through feed. Among the medicated pigs, total tylosin dose 
administered was the greatest through injection, second highest through feed, with the 
water medication route the lowest. No evidence for route × day interactions (P > 0.23) 
were observed for the development of bacterial resistance to any antibiotics. Enterococcal 
isolates collected from pigs receiving tylosin via feed or injection were more resistant 
1This study was supported in part by a grant from the National Pork Board (#16-053). 
2Department of Diagnostic Medicine/Pathology, College of Veterinary Medicine, Kansas State University. 
3Department of Statistics, College of Arts and Sciences, Kansas State University
4Department of Clinical Sciences, College of Veterinary Medicine, Kansas State University.
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(P < 0.05) to erythromycin and tylosin compared with control pigs and those that 
received tylosin through water. The estimated probability of antimicrobial resistance to 
these 2 antibiotics was greater on d 21 and 35 than d 0. In summary, tylosin injection 
resulted in poorer ADG and F/G of finishing pigs, likely due to stress associated with 
handling and injection. Tylosin administration through injection and feed resulted in 
greater probability of enterococcal resistance to erythromycin and tylosin compared 
with in-water treatment, which is likely a combined effect of administration route and 
dosage.
Introduction
Use of antimicrobial feed additives to promote growth has been a valuable tool for 
efficient swine production for the past six decades. However, the emergence of antimi-
crobial resistance constitutes a major public health concern. Therefore, in swine produc-
tion systems, there is considerable interest and effort in identifying feeding and manage-
ment practices that maintain and improve production efficiency without promoting the 
occurrence of antimicrobial resistance in bacteria. 
Antibiotics are administered either in feed, in water, or parenterally. The oral route 
through either feed or water is by far the most common route of administration of 
antibiotics. Oral administration is more convenient when treating a large number of 
animals compared with individual pig treatment through the injectable route. Never-
theless, oral administration exposes gut bacteria directly to high concentrations of 
antibiotics and thus has been hypothesized to have a greater potential in promoting 
the emergence and amplification of antimicrobial resistance. However, to our knowl-
edge, no study has been carried out to compare the impacts of oral administration 
through feed or water versus injectable antibiotic administration on the development 
of resistance in pigs. Therefore, the objective of this study was to determine the effects 
of tylosin administration route on the growth performance and the development of 
antimicrobial resistance in fecal enterococci of finishing pigs.
Procedures
The Kansas State University Institutional Animal Care and Use Committee approved 
the protocol used in this experiment. The study was conducted at the Kansas State 
University Swine Teaching and Research Center in Manhattan, KS. Pigs were housed 
in an environmentally controlled barn with a completely slatted concrete floor. Each 
pen (5 × 5 ft) was equipped with a single-hole stainless steel feeder and cup waterer 
for ad libitum access to feed and water. Each drinker was equipped with an individual 
water reservoir and water cup allowing for independent water treatment. Each 2 pens 
(1 barrow pen and 1 gilt pen sharing the same treatment) were segregated by solid pen 
dividers to minimize nasal contact and manure cross-contamination among pigs from 
different treatment groups.
A total of 40 barrows and 40 gilts (Line 600 × 241; DNA, Columbus, NE; initially 
207 ± 7.9 lb) were individually housed and used in a 35-d trial. Pigs were individu-
ally weighed, blocked by initial BW, gender, and barn location, and assigned to pens 
17 d prior to the start of the experiment. Early allotment was done in order to avoid 
pig movement across pens on d 0 and minimize cross-contamination for fecal sample 
collection. On d 0, experimental treatments were assigned to pens, which include: 
Kansas State University Agricultural Experiment Station and Cooperative Extension Service
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1) pigs fed a corn-soybean meal-based diet (Table 1) with no antibiotic (Control); 
2) pigs fed the control diet with 110 ppm of tylosin (100 g Tylan®100/ton of feed; 
Elanco Animal Health, Indianapolis, IN) per kg feed for 21 d (Feed); 3) pigs fed the 
control diet and received 8.82 mg injectable tylosin (1 mL Tylan®200/50 lb BW; Elanco 
Animal Health, Indianapolis, IN) per kg of BW twice daily for the first 3 d of each 
week during the 3-wk treatment period (Injection); and 4) pigs fed the control diet 
and received 66 mg of tylosin (Tylan®Soluble; Elanco Animal Health, Indianapolis, IN) 
per L of drinking water for the first 3 d of each week during the 3-wk treatment 
period (Water). Antibiotic treatments were terminated on d 21 and all pigs were fed a 
common diet from d 21 to 35. 
Pigs were weighed and feed disappearance was recorded on d 0, 7, 14, 21, 28, and 35 
to determine ADG, ADFI, and F/G. The water reservoir was weighed and refilled 
twice daily to determine daily water consumption for each pig. Previously, all pigs had 
received dietary chlortetracycline and tiamulin for approximately 14 d immediately 
after weaning; however, pigs were not treated by other antibiotics through feed or water 
from d 14 after weaning until the start of experimental treatments.
All diets were provided in meal form and were manufactured by the Kansas State 
University O.H. Kruse Feed Technology Innovation Center, Manhattan, KS. 
Complete diet samples were obtained and delivered to Kansas State University Swine 
Laboratory, Manhattan, KS, and stored at -4°F until analysis. Feed samples were 
analyzed for dry matter (DM), crude protein (CP), ether extract, calcium (Ca), and 
phosphorus (P) (Ward Laboratories, Inc., Kearney, NE).
Fecal samples were collected into individual Whirl-Pak bags (Nasco, Ft. Atkinson, 
WI) on d 0 (baseline), 21 (end of treatment period), and 35 (end of common period). 
Samples were transported on ice to the Molecular Epidemiology and Microbial Ecology 
laboratory at Kansas State University (Manhattan, KS) for bacterial isolation and anti-
microbial susceptibility analysis.
Fecal samples were stored at 39.2°F prior to processing. Approximately 1 g of feces from 
each sample was suspended in 9 mL of phosphate buffer saline. Fifty microliters of the 
fecal suspension were then spread plated onto M-Enterococcus agar plates for the selec-
tive isolation of Enterococcus spp. from each fecal sample. Unless otherwise specified, all 
the culture media was obtained from Difco (Becton, Dickinson and Company, Sparks, 
MD). M-Enterococcus plates were incubated at 107.6°F for 24 to 36 h. Two putative 
colonies (pin-point red, pink, or metallic red) were selected from each M-Enterococcus 
agar; each of these colonies was individually streaked onto a blood agar plate (Remel, 
Lenexa, KS) and incubated at 98.6°F for 24 h. Preliminary genus confirmation of each 
of the enterococcal isolates was done by esculin hydrolysis. The 2 confirmed Entero-
coccus isolates per original fecal sample were preserved using cryo-protect beads (Cryo-
care; Key Scientific Products, Round Rock, TX) and stored at −112°F for future use.5 
5Amachawadi, R. G., N. W. Shelton, X. Shi, J. Vinasco, S. S. Dritz, M. D. Tokach, J. L. Nelssen, H. 
M. Scott, and T. G. Nagaraja. 2011. Selection of tcrB gene mediated copper resistant fecal enterococci 
in pigs fed diets supplemented with copper. Appl. Environ. Microbiol. 77:5597–5603. doi:10.1128/
AEM.00364-11.
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The microbroth dilution method as outlined by the Clinical and Laboratory Standards 
Institute (2013)6 was used on one of each Enterococcus spp. bacterial isolate per original 
fecal sample to determine the minimal inhibitory concentrations using a Sensititre 
(TREK Diagnostic Systems, Oakwood Village, OH) micro-broth dilution procedure. 
Enterococcus spp., bacterial isolate preserved in cryo-protect beads was streaked onto 
a blood agar plate and incubated at 98.6°F for 24 h. Individual colonies were selected 
and suspended in demineralized water (TREK Diagnostic Systems) and turbidity was 
adjusted to 0.5 McFarland turbidity standards. Then, 10 μL of the bacterial inoculum 
was added to Mueller–Hinton broth and vortexed to mix. A Sensititre automated 
inoculation delivery system (TREK Diagnostic Systems) was used to dispense 100 
μL of the broth into National Antimicrobial Resistance Monitoring System panel 
plates designed for Gram-positive (CMV3AGPF; TREK Diagnostic Systems; Table 
2) bacteria. Enterococcus faecalis ATCC 29212 (American Type Culture Collection, 
Manassas, VA) strains were included as quality controls for Enterococcus susceptibility 
testing. Plates were incubated at 98.6°F for 18 h and then bacterial growth was assessed 
using Sensititre ARIS and Vizion systems (TREK Diagnostic Systems). Clinical and 
Laboratory Standards Institute guidelines were used to classify each bacterial isolate as 
resistant or nonresistant (intermediate and susceptible) according to the breakpoints 
established for each antimicrobial.6
All response criteria were analyzed using generalized linear mixed models. The linear 
predictors included the fixed effects of tylosin administration route (control, in-feed, 
injectable, and water), gender (gilt and barrow), and their interaction. The model also 
included the random effects of BW and location block and block × route interaction. 
The random effect was used to identify a pair of pens with 1 barrow pen and 1 gilt pen 
sharing the same treatment as the level of replication for tylosin administration route. 
Growth performance responses as well as water and medication intake were measured 
at the pen level. Residual assumptions were checked using Studentized residuals. For 
antimicrobial resistance data, frequency tables of resistant and nonresistant isolates 
for each antibiotic were initially evaluated. For gentamicin, kanamycin, streptomycin, 
and vancomycin, none of the fecal isolates were categorized as resistant and thus no 
further statistical analyses were performed. For each remaining antibiotic, subcategory 
frequency tables were further evaluated for tylosin administration route, sampling day, 
and their interaction. These tables were used to identify potential extreme category 
problems during model fitting. Subcategories with all resistant or nonresistant isolates 
or frequencies close to these extremes can lead to model fitting problems due to zero 
variance components. 
Antimicrobial resistance probability was analyzed using a model assuming a Bernoulli 
distribution response and a logit link function. Due to the presence of subcategory 
extremes, it was not possible to fit the 3-way interaction among administration route, 
sampling day, and gender for chloramphenicol, linezolid, nitrofurantoin, penicillin, 
quinupristin/dalfopristin, tigecycline, ciprofloxacin, daptomycin, erythromycin, 
lincomycin, tetracycline, and tylosin. In addition, 2-way interactions with administra-
6Clinical and Laboratory Standards Institute. 2013. Performance standards for antimicrobial disk and 
dilution susceptibility tests for bacteria isolated from animals. Approved Standard, 4th Ed. Document 
VET01-A4. CLSI, Wayne, PA.
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tion route by sampling day were eliminated for linezolid, nitrofurantoin, penicillin, 
quinupristin/dalfopristin, and tigecycline, as well as any interaction involving gender 
for ciprofloxacin, daptomicin, erythromycin, lincomycin, tetracycline, and tylosin. 
Overdispersion was assessed using the maximum-likelihood-based fit statistic Pearson 
Chi-Square over degree of freedom. In all cases, final models used for inference showed 
no evidence for overdispersion.
Pairwise comparisons were conducted using a Tukey-Kramer or Bonferroni adjust-
ment. Statistical models were fit using the GLIMMIX procedure of SAS (Version 9.4; 
SAS Inst. Inc., Cary, NC). In all cases, the final model used for inference was fit using 
residual (pseudo-) likelihood implemented with a Newton-Raphson optimization with 
ridging. Least square mean estimates of probability of resistance are presented, along 
with corresponding 95% confidence intervals. Results were considered significant at 
P ≤ 0.05, and marginally significant with P-values > 0.05 and ≤ 0.10.
Results and Discussion
Growth Performance
No evidence for route × gender interactions (P > 0.55) were observed for any of the 
growth responses (Table 3). During the treatment period (d 0 to 21), the main effect 
of administration route marginally contributed to explain ADG (P = 0.100), whereby 
the control pigs and pigs fed medicated feed had greater (P < 0.05) ADG than those 
receiving tylosin through injection, with the ADG of pigs receiving tylosin through 
water intermediate. For the main effect of gender, barrows grew marginally faster (P 
= 0.091) than gilts during the treatment period. Average daily feed intake was greater 
(P = 0.031) in barrows than in gilts but there was no evidence for any effect of tylosin 
administration route on ADFI. Feeding tylosin resulted in similar F/G as that of pigs 
receiving no antibiotic treatment. In contrast, administration of tylosin through injec-
tion or water worsened F/G (P < 0.05) compared with pigs from the control group. No 
evidence of gender effect was observed for F/G during the treatment period. During the 
post-treatment period (d 21 to 35), no evidence for any effects of administration route 
or gender were observed for any growth responses. Overall (d 0 to 35), growth perfor-
mance was not influenced by the tylosin administration route; barrows had marginally 
greater (P = 0.071) ADFI than gilts but no evidence of different ADG or F/G were 
observed. 
For average daily water intake, there was no evidence for any effects of tylosin admin-
istration route nor gender. Among the medicated pigs, total tylosin dose administered 
was the greatest through injection, second highest through feed, with the water medica-
tion route the lowest (P < 0.01).
Antimicrobial Resistance
Table 4 illustrates the estimated probability of antimicrobial resistance of enterococcal 
isolates, in response to tylosin administration route and sampling day, to antibiotics of 
critically importance to human medicine,7 namely ciprofloxacin, daptomycin, erythro-
mycin, gentamicin, kanamycin, linezolid, penicillin, streptomycin, tigecycline, tylosin, 
7World Health Organization. 2012. Critically important antimicrobials for human medicine – 3rd rev. 
WHO Document Production Services, Geneva, Switzerland.
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and vancomycin. No enterococcal isolates showed any resistance to gentamicin, kana-
mycin, streptomycin, and vancomycin for the duration of the study. For ciprofloxacin, 
there was no evidence for any interactive or main effects of tylosin administration route, 
gender, or sampling day on antimicrobial resistance in the study period. For dapto-
mycin, only a main effect of sampling day was apparent on antimicrobial resistance 
(P < 0.001), whereby regardless of administration route or gender, the probability of 
resistance decreased during treatment period and increased thereafter (57, 27, and 46% 
on d 0, 21, and 35, respectively). There was no evidence of any tylosin administration 
route effect on antimicrobial resistance to daptomycin. For erythromycin, no evidence 
of route × sampling day interaction was apparent, but both main effects significantly 
(P < 0.05) contributed to explain antimicrobial resistance. Overall, the probability of 
antimicrobial resistance to erythromycin was marginally greater (P < 0.10) when gilts or 
barrows received tylosin via either feed or injection relative to water (76, 78, and 52%, 
respectively), with that of control pigs (57%) intermediate. Moreover, the probability 
of resistance to erythromycin increased from d 0 to d 21 and d 35 (50, 75, and 73%, 
respectively), regardless of tylosin administration route. For linezolid, penicillin, and 
tigecycline, there was no evidence for any effects of tylosin administration route, gender, 
and sampling day on antimicrobial resistance. For tylosin, the main effect of adminis-
tration route marginally contributed to explain antimicrobial resistance (P = 0.068), 
whereby the probability of resistance to tylosin was greater (P < 0.05) in enterococcal 
isolates collected from pigs receiving tylosin via feed and injection (69 and 70%, respec-
tively) compared with control pigs and those receiving oral tylosin through drinking 
water (50 and 50%, respectively). The probability of resistance to tylosin increased (P < 
0.01) from d 0 to d 21 and d 35 (41, 70, and 68%, respectively). 
Table 5 shows the estimated probability of antimicrobial resistance of enterococcal 
isolates to antibiotics considered highly important or important to human medicine, 
namely chloramphenicol, quinupristin/dalforistin, lincomycin, tetracycline, and nitro-
furantoin (WHO, 2012). There was no evidence for any effects of tylosin administra-
tion route, gender, and sampling day on antimicrobial resistance to chloramphenicol, 
quinupristin/dalforistin, lincomycin, and tetracycline. For nitrofurantoin, only the 
main effect of sampling day significantly contributed to explain antimicrobial resistance 
(P = 0.002), whereby the probability of resistance to nitrofurantoin remained similar 
during treatment period and decreased (P < 0.01) thereafter (22, 27, and 2% on d 0, 21, 
and 35, respectively) regardless of gender or tylosin administration routes. 
It has been reported in studies (NCR-89 Committee on Confinement Management of 
Swine, 1986;8 Pilcher et al., 20159) that feeding tylosin at a low dosage (44 or 22 ppm) 
promoted ADG and F/G of growing-finishing pigs. However, other studies (Lillie et al., 
8NCR-89 Committee on Confinement Management of Swine. 1986. Effect of space allowance and 
tylosin feeding on performance of growing-finishing pigs. J. Anim. Sci. 62:871–874. 
9Pilcher, C. M., R. Arentson, and J. F. Patience. 2015. The interaction of fiber, supplied by distillers dried 
grains with solubles, with an antimicrobial and a nutrient partitioning agent on nitrogen balance, water 
utilization, and energy digestibility in finishing pigs. J. Anim. Sci. 93:1124–1132. doi:10.2527/jas2013-
7309 
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1997;10 Dritz et al., 2002;11 Van Lunen et al., 200312) have suggested a lack of growth-
promoting response of tylosin when fed to finishing pigs. In the present study, we did 
not observe any evidence for a difference in growth performance among pigs fed tylosin-
medicated feed and those with no antibiotic treatment. A potential reason for this 
observation is the excellent performance of control pigs; pigs in the present study were 
individually housed and had approximately 15% greater ADFI and 20% greater ADG 
than the normally group-housed pigs of similar weight range and raised on the same 
research site. In addition, the good hygienic conditions of a university research environ-
ment may have also contributed to the lack of growth response to feed antibiotic. Pigs 
from the injection group had poorer ADG and F/G than control pigs, which was likely 
a result of stress associated with the injection procedure. However, it remains unclear 
why pigs offered medicated water were less feed efficient than control pigs.
We initially hypothesized that oral administration exposes gut bacteria directly to high 
concentrations of antibiotics, thus creating a greater potential in promoting the devel-
opment of antimicrobial resistance. However, results from the present study suggested 
greater promoting effects of injectable and in-feed tylosin on the development of 
enterococcal resistance to erythromycin and tylosin over the oral water administration 
routes. Two possible reasons can be speculated for this observation. The first is potential 
excretion of injected tylosin and its metabolites into the gastrointestinal tract of pigs 
that exerted selection pressure on bacteria to become resistant. Secretion from the liver 
into the gastrointestinal tract and urinary excretion of absorbed tylosin and the metabo-
lite desmycosin has been reported (Worth, 1971;13 Wal and Bories, 197314). Secondly, 
the effects of administration route on the development of antimicrobial resistance may 
be dose-dependent. The treatment dose and procedure administered in each tested 
route followed the label instruction of corresponding tylosin product. Based on these 
dosages, pigs provided the oral water treatment received only 21 and 43% of the total 
tylosin doses administered to those on the injection and in-feed treatments, respectively 
(Table 3). Moreover, a recent review by Pyöräla et al.15 has suggested that applying 
macrolide antibiotics, including tylosin, in feed or through injections creates long-
acting concentrations of active substance in pigs, which may particularly contribute to 
the development of antimicrobial resistance. The slow absorption and release of tylosin 
in injected pigs and the uninterrupted tylosin administration through feed may have 
10Lillie, R. J., L. T. Frobish, N. C. Steele, and G. Graber. 1977. Effect of dietary copper and tylosin and 
subsequent withdrawal on growth, hematology and tissue residues of growing-finishing pigs. J. Anim. Sci. 
45:100–107.
11Dritz, S. S., M. D. Tokach, R. D. Goodband, and J. L. Nelssen. 2002. Effects of administration of anti-
microbials in feed on growth rate and feed efficiency of pigs in multisite production systems. J. Am. Vet. 
Med. Assoc. 220:1690–1695. 
12Van Lunen, T. A. 2003. Growth performance of pigs fed diets with and without tylosin phosphate 
supplementation and reared in a biosecure all-in all-out housing system. Can. Vet. J. 44:571–576. 
13Worth, H. M. 1971. How do safety evaluations and residues studies assure wholesome pork. Sympo-
sium proceedings: Swine feed additives, producer and consumer. University of Kentucky, College of 
Agriculture, Lexington. p. 61.
14Wal, J. M. and Bories, G. F. 1973. Tritiation of tylosin and metabolic study in the rat. J. Antibiot. 
26:687–691. 
15Pyörälä, S., K. E. Baptiste, B. Catry, E. van Duijkere, C. Greko, M. A. Moreno, M. C. Pomba, M. 
Rantala, M. Ružauskas, P. Sanders, E. J. Threlfall, J. Torren-Endo, and K. Törneke. 2014. Macrolides and 
lincosamides in cattle and pigs: Use and development of antimicrobial resistance. Vet J. 200:230–239. 
https://doi.org/10.1016/j. tvjl.2014.02.028.
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created continuous selection pressure on resistant bacteria in contrast to the lower 
dosage and intermittently administered tylosin treatment through water.
In addition, it is surprising that we did not observe any evidence for a route × day inter-
action for the development of resistance to tylosin and erythromycin. This suggested an 
increased resistance rate over time even in enterococcal isolates collected from pigs that 
received no tylosin treatment. It is possible that the resistant bacteria might have been 
transmitted from the tylosin-treated pigs to control pigs through fecal contamination 
even though isolation measures were provided among pens. Indirect physical contact of 
pigs via personnel movement across pens could also lead to contamination of resistant 
bacteria. However, we currently cannot explain the reason why the resistance of entero-
coccal isolates to daptomycin was decreased from baseline to treatment period and then 
increased back to baseline levels after a 2 wk wash-out period (Table 4). 
In summary, feeding tylosin did not promote the growth performance of finishing pigs; 
in contrast, tylosin injection harmed ADG and F/G. We hypothesize this is due to 
stress associated with the injection procedure. Tylosin administration through injec-
tion and feed resulted in more prevalent resistance to erythromycin and tylosin in fecal 
enteroccocal isolates compared with those collected from pigs that received no or oral 
tylosin through the water. We hypothesize that the total tylosin dosage could have 
affected the resistance response to administration route because the oral treatment 
through the water resulted in a lower dose administered than the injection and in-feed 
treatments. 
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Table 1. Diet composition (as-fed basis)
  Non-medicated Medicated
Corn 85.95 85.90
Soybean meal 11.91 11.91





Trace mineral premix 0.10 0.10
Vitamin premix 0.08 0.08
Phytase1 0.02 0.02
Tylan 1002 --- 0.05
Total 100.00 100.00
Calculated composition









Total Lys, % 0.74 0.74
Crude protein, % 13.02 13.02
Net energy, kcal/lb  1,159 1,158 
Ca, % 0.45 0.45
P, % 0.39 0.39
STTD P with phytase,3 % 0.28 0.28
Analyzed composition, %
Dry matter 89.69 89.60




1Ronozyme Hiphos 2700 (DSM Nutritional Products, Inc., Parsippany, NJ), providing 184.3 phytase units 
(FTU)/lb and an estimated release of 0.10% available P.
2Elanco Animal Health (Indianapolis, IN).
3STTD = standardized total tract digestible.
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Table 2. Resistance breakpoints and evaluated concentrations for antimicrobials of 
National Antimicrobial Resistance Monitoring System Gram-positive bacteria panel 






Chloramphenicol Highly important 2-32 ≥32
Ciprofloxacin Critically important 0.12-4 ≥4
Daptomycin Critically important 0.25-16 N/A3
Erythromycin Critically important 0.25-8 ≥8
Gentamicin Critically important 128-1,024 >500
Kanamycin Critically important 128-1,024 ≥1,024
Lincomycin Highly important 1-8 ≥8
Linezolid Critically important 0.5-8 ≥8
Nitrofurantoin Important 2-64 ≥128
Penicillin Critically important 0.25-16 ≥16
Quinupristin/alfopristin Highly important 0.5-32 ≥4
Streptomycin Critically important 512-2,048 >1000
Tetracycline Highly important 1-32 ≥16
Tigecycline Critically important 0.015-0.5 N/A4
Tylosin tartrate Critically important 0.25-32 ≥32
Vancomycin Critically important 0.25-32 ≥32
1World Health Organization (WHO) categorization of antimicrobials according to importance for human medi-
cine (WHO, 2012). 
2Breakpoints established by Clinical and Laboratory Standards Institute (2013). 
3N/A = not applicable. A susceptibility breakpoint of ≤ 4 μg/mL for daptomycin exists but no resistant breakpoint 
has been established. In this study, isolates with a minimal inhibitory concentration ≥ 8 μg/mL were categorized as 
resistant. 
4A susceptibility breakpoint of ≤ 0.25 μg/mL for tigecycline exists but no resistant breakpoint has been established. 
In this study, isolates with a minimal inhibitory concentration ≥ 0.5 μg/mL were categorized as resistant. 
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Table 3. Effects of tylosin administration route and gender on growth performance of finishing pigs1
Route2 Gender P <
  Control Feed Injection Water SEM Barrow Gilt SEM Route Gender
Route × 
gender
Treatment (d 0 to 21)
ADG, lb 2.77a 2.78a 2.54b 2.69ab 0.074 2.75 2.64 0.051 0.100 0.091 0.551
ADFI, lb 8.02 8.20 7.83 8.43 0.218 8.33 7.91 0.157 0.219 0.031 0.824
F/G 2.90b 2.97ab 3.10a 3.14a 0.062 3.04 3.01 0.038 0.058 0.618 0.702
Post-treatment (d 21 to 35)
ADG, lb 2.64 2.68 2.55 2.59 0.071 2.62 2.61 0.053 0.569 0.882 0.991
ADFI, lb 8.24 8.13 7.78 8.09 0.177 8.16 7.96 0.153 0.178 0.304 0.903
F/G 3.13 3.05 3.09 3.15 0.068 3.14 3.08 0.058 0.697 0.429 0.916
Overall (d 0 to 35)
ADG, lb 2.72 2.74 2.54 2.65 0.060 2.70 2.63 0.038 0.127 0.159 0.746
ADFI, lb 8.11 8.17 7.81 8.29 0.187 8.26 7.93 0.146 0.241 0.071 0.844
F/G 2.98 2.99 3.09 3.13 0.051 3.07 3.03 0.032 0.151 0.289 0.560
Water 
intake, L
6.14 6.45 6.87 6.06 0.287 6.56 6.20 0.241 0.179 0.310 0.566
Tylosin 
intake, g
- 8.61b 18.00a 3.69c 0.148 10.20 10.01 0.123 0.001 0.262 0.425
1There were a total of 40 barrows and 40 gilts (Line 600 × 241, DNA, Columbus, NE; initially 207 ± 7.9 lb) housed with 1 pig per pen and 10 replicate pens per 
treatment per gender.
2Control = pigs received no antibiotic; feed = pigs received 110 mg tylosin per kg feed for 21 d; injection = pigs received 8.82 mg tylosin per kg BW through intra-
muscular injection twice daily for the first 3 d of each wk during the 3-wk treatment period; water = 66 mg tylosin per liter of drinking water for the first 3 d of each 
wk during treatment period.
abcMeans with different superscripts within a row differ (P < 0.05). 
ADG = average daily gain. ADFI = average daily feed intake. F/G = feed efficiency.
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Table 4. Effects of tylosin administration route and time on fecal enterococci resistant prevalence to critically impor-
tant antimicrobials1
Route2 Probability, P <
Control Feed Injection Water Route Day
Route × 
day
Ciprofloxacin 0.318 0.904 0.986
Baseline (d 0) 10 [2, 33]3 20 [8, 43] 20 [8, 43] 0 [.]
Treatment (d 21) 10 [2, 33] 25 [11, 48] 20 [8, 43] 15 [5, 38]
Post-treatment (d 35) 10 [2, 33] 25 [11, 48] 10 [2, 33] 15 [5, 38]
Daptomycin 0.312 0.001 0.708
Baseline (d 0) 70 [47, 86] 55 [33, 75] 60 [38, 79] 40 [21, 62]
Treatment (d 21) 40 [21, 62] 25 [11, 48] 25 [11, 48] 20 [8, 43]
Post-treatment (d 35) 50 [29, 71] 40 [21, 62] 40 [21, 62] 55 [33, 75]
Erythromycin 0.025 0.004 0.258
Baseline (d 0) 55 [33, 76] 65 [42, 83] 45 [24, 67] 35 [17, 58]
Treatment (d 21) 50 [28, 71] 80 [57, 93] 95 [72, 99] 50 [28, 71]
Post-treatment (d 35) 65 [42, 83] 80 [57, 93] 75 [51, 90] 70 [46, 87]
Gentamicin N/A4 N/A N/A
Baseline (d 0) 0 [.] 0 [.] 0 [.] 0 [.]
Treatment (d 21) 0 [.] 0 [.] 0 [.] 0 [.]
Post-treatment (d 35) 0 [.] 0 [.] 0 [.] 0 [.]
Kanamycin N/A N/A N/A
Baseline (d 0) 0 [.] 0 [.] 0 [.] 0 [.]
Treatment (d 21) 0 [.] 0 [.] 0 [.] 0 [.]
Post-treatment (d 35) 0 [.] 0 [.] 0 [.] 0 [.]
Linezolid 0.688 0.942 -
Baseline (d 0) 0 [.] 20 [8, 42] 10 [2, 35] 0 [.]
Treatment (d 21) 20 [7, 47] 10 [2, 35] 0 [.] 0 [.]
Post-treatment (d 35) 15 [5, 37] 10 [3, 32] 10 [3, 32] 0 [.]
Penicillin 0.697 0.187 -
Baseline (d 0) 5 [0.7, 27] 10 [2, 33] 0 [.] 0 [.]
Treatment (d 21) 0 [.] 5 [0.7, 27] 0 [.] 0 [.]
Post-treatment (d 35) 10 [2, 33] 10 [2, 33] 10 [2, 33] 0 [.]
Streptomycin N/A N/A N/A
Baseline (d 0) 0 [.] 0 [.] 0 [.] 0 [.]
Treatment (d 21) 0 [.] 0 [.] 0 [.] 0 [.]
Post-treatment (d 35) 0 [.] 0 [.] 0 [.] 0 [.]
continued
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Table 4. Effects of tylosin administration route and time on fecal enterococci resistant prevalence to critically impor-
tant antimicrobials1
Route2 Probability, P <
Control Feed Injection Water Route Day
Route × 
day
Tigecycline 0.279 0.832 -
Baseline (d 0) 85 [63, 95] 90 [68, 98] 95 [71, 99] 100 [.]
Treatment (d 21) 90 [68, 98] 90 [68, 98] 100 [.] 95 [74, 99]
Post-treatment (d 35) 90 [68, 98] 90 [68, 98] 100 [.] 85 [62, 95]
Tylosin 0.068 0.001 0.233
Baseline (d 0) 45 [24, 68] 55 [32, 76] 30 [13, 54] 35 [17, 58]
Treatment (d 21) 50 [28, 72] 75 [51, 90] 90 [67, 98] 50 [28, 72]
Post-treatment (d 35) 55 [32, 76] 75 [51, 89] 75 [51, 89] 65 [41, 83]
Vancomycin N/A N/A N/A
Baseline (d 0) 0 [.] 0 [.] 0 [.] 0 [.]
Treatment (d 21) 0 [.] 0 [.] 0 [.] 0 [.]
Post-treatment (d 35) 0 [.] 0 [.] 0 [.] 0 [.]
1Values represent the estimated probability of resistance among 20 enterococcal isolates per sampling day (d 0, 21, or 35); susceptibility was determined 
according to National Antimicrobial Resistance Monitoring System (CLSI, 2013, footnote 6 from main text) established breakpoints. One fecal sample 
was collected per pen per day and 1 enterococcal isolate per fecal sample was assessed. There was a total of 80 pigs (Line 600 × 241, DNA, Columbus, 
NE; initially 207 ± 7.9 lb) housed with 1 pig per pen and 10 replicate pens per treatment per gender. 
2Control = pigs received no antibiotic; feed = pigs received 110 mg tylosin per kg feed for 21 d; injection = pigs received 8.82 mg tylosin per kg BW 
through intramuscular injection twice daily for the first 3 d of each wk during the 3-wk treatment period; water = 66 mg tylosin per liter of drinking 
water for the first 3 d of each wk during treatment period.
3Indicates 95% confidence interval.
4N/A represents statistics were not conducted because all enterococcal isolates were identified as susceptible.
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Table 5. Effects of tylosin administration route and time on the fecal enterococci resistant prevalence to highly 
important and important antimicrobials1
  Route2   Probability, P <
  Control Feed Injection Water Route Day
Route × 
day
Chloramphenicol 0.331 0.234 0.935
Baseline (d 0) 19 [7, 44]3 14 [4, 38] 3 [0.3, 26] 4 [0.4, 28]
Treatment (d 21) 10 [2, 33] 9 [2, 32] 4 [0.4, 28] 5 [0.4, 28]
Post-treatment (d 35) 19 [7, 44] 14 [4, 38] 19 [7, 44] 8 [2, 32]
Lincomycin 0.996 0.555 0.340
Baseline (d 0) 95 [72, 99] 86 [61, 96] 76 [52, 90] 91 [67, 98]
Treatment (d 21) 100 [.] 91 [67, 98] 95 [71, 99] 81 [56, 93]
Post-treatment (d 35) 86 [62, 96] 95 [72, 99] 95 [72, 99] 95 [72, 99]
Nitrofurantoin 0.331 0.002 -
Baseline (d 0) 20 [7, 43] 10 [2, 33] 35 [17, 58] 25 [10, 49]
Treatment (d 21) 25 [10, 49] 30 [13, 54] 15 [5, 38] 40 [20, 63]
Post-treatment (d 35) 0 [.] 0 [.] 0 [.] 10 [3, 31]
Quinupristin/Dalfopristin 0.688 0.942 -
Baseline (d 0) 0 [.] 20 [8, 42] 10 [2, 35] 0 [.]
Treatment (d 21) 20 [7, 47] 10 [2, 35] 0 [.] 0 [.]
Post-treatment (d 35) 15 [5, 37] 10 [3, 32] 10 [3, 32] 0 [.]
Tetracycline 0.753 0.104 0.747
Baseline (d 0) 80 [55, 93] 80 [55, 93] 75 [50, 90] 80 [55, 93]
Treatment (d 21) 80 [55, 93] 90 [65, 98] 95 [70, 99] 80 [55, 93]
Post-treatment (d 35) 90 [65, 98] 85 [60, 96] 95 [70, 99] 90 [65, 98]
1Values represent the estimated probability of resistance among 20 enterococcal isolates per sampling day (d 0, 21, or 35); susceptibility was determined 
according to National Antimicrobial Resistance Monitoring System (CLSI, 2013, footnote 6 from main text) established breakpoints. One fecal sample 
was collected per pen per day and 1 enterococcal isolate per fecal sample was assessed. There was a total of 80 pigs (Line 600 × 241, DNA, Columbus, 
NE; initially 207 ± 7.9 lb) housed with 1 pig per pen and 10 replicate pens per treatment per gender. 
2Control = pigs received no antibiotic; feed = pigs received 110 mg tylosin per kg feed for 21 d; injection = pigs received 8.82 mg tylosin per kg BW 
through intramuscular injection twice daily for the first 3 d of each wk during the 3-wk treatment period; water = 66 mg tylosin per liter of drinking 
water for the first 3 d of each wk during treatment period.
3Indicates 95% confidence interval.
